Predicta Biosciences is a precision oncology company integrating cutting edge multiomics and liquid biopsies to develop innovative diagnostic and therapeutic products. Predicta's diagnostic product portfolio removes the burden of bone-marrow biopsies, through small blood-based samples, and enables best-in-class treatment decision-making for immunotherapies. Utilizing the data from the diagnostic platform, Predicta has an in-house therapeutic pipeline of novel immunotherapy targets in pre-clinical discovery and development.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 750 Main St, Cambridge,massachusetts 02139,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://predictabiosciences.com
- Keywords
- Copenhagen.
- HQ
- Cambridge, Massachusetts
Predicta Biosciences Questions
Predicta Biosciences's website is http://predictabiosciences.com
Predicta Biosciences's LinkedIn profile is https://www.linkedin.com/company/predicta-biosciences
Predicta Biosciences has
6 employees.
View email and phone details for 6
employees at Predicta Biosciences.
Predicta Biosciences's industry is
Biotechnology Research
Predicta Biosciences's top competitors are
Gnosko Bio,
Maxim Biotech Inc,
Nowdiagnostics | Nowdx,
Singlera Genomics Incorporated,
Kvantify,
Gelomics,
Element Biosciences,
Phycin,
Trueyouomics,
Mingceler Turbomice.
Predicta Biosciences's categories are Biotechnology Research
Predicta Biosciences's founding year is 2023
